Neuroblastoma
Neuroblastoma is the second most solid tumour in children which affects around 7% of all children with cancer. It is a cancer that progresses from immature nerve cells found in several areas of the body. Neuroblastoma most frequently occurs in and around the adrenal glands, which have similar origins to nerve cells and sit over the kidneys. It can also occur in other areas of the abdomen chest, neck and near the spine, where clusters of nerve cells exist. Neuroblastoma begins in very initial forms of nerve cells, frequently found in an embryo or fetus. Occasionally it forms before birth and can be found during a fetal ultrasound.
Related Conference of Neuroblastoma
April 21-22, 2025
16th International Conference on Cancer Stem Cell & Oncology Research
Amsterdam, Netherlands
November 24-25, 2025
47th Euro-Global Summit on Cancer Therapy & Radiation Oncology
Barcelona, Spain
Neuroblastoma Conference Speakers
Recommended Sessions
- Pediatric Dermatology
- Clinical Neonatology
- Clinical Pediatrics
- Neonatal & Pediatric Endocrinology
- Neonatal & Pediatric Hematology
- Neonatal & Pediatric Imaging
- Neonatal & Pediatric Immunology
- Neonatal & Pediatric leukemia
- Neonatal & Pediatric Nutrition
- Neonatal & Pediatric Oncology
- Neonatal & Pediatric Oncology Diagnosis
- Neonatal & Pediatric Pulmonology
- Neonatal & Pediatric Radiology
- Neonatology & Pediatrics
- Neuroblastoma
- Palliative care for Cancer
- Pediatric Neuro Oncology
- Pediatric Oncology Nursing
- Therapies in Neonatal & Pediatric Oncology
Related Journals
Are you interested in
- Advancements in Oncology Nursing: Trends and Best Practicss - World Cancer 2025 (UK)
- Advancements in Tumor Microenvironment Targeting - Cancer Biology 2025 (UK)
- Advances in Cancer Biomarkers - Biomarkers Conference 2025 (Italy)
- Advances in Cancer Prevention and Risk Assessment - Preventive Oncology 2025 (Italy)
- Advances in Cell-Based Drug Delivery Systems - Cancer Biology 2025 (UK)
- AI and Machine Learning in Cancer Care - CANCER2025 (Netherlands)
- Artificial Intelligence in Cancer Research - CANCER BIOLOGY- 2025 (Italy)
- Artificial Intelligence in Cancer Research - CANCER BIOLOGY- 2025 (Italy)
- Autophagy and Cancer Cell Survival Mechanisms - Cancer Biology 2025 (UK)
- Basic and Translational Research - ORAL CANCER SUMMIT 2025 (France)
- Bioinformatics and Biomarkers - Biomarkers Conference 2025 (Italy)
- Biomarker Detection Technologies - Biomarkers Conference 2025 (Italy)
- Biomarkers and Liquid Biopsy - CANCER BIOLOGY- 2025 (Italy)
- Biomarkers and Liquid Biopsy - CANCER BIOLOGY- 2025 (Italy)
- Biomarkers in Drug Development - Biomarkers Conference 2025 (Italy)
- Breast Cancer - Breast Cancer Summit 2025 (Italy)
- Breast Cancer - Breast Cancer-2025 (Germany)
- Breast cancer and cell biology - Breast Cancer Summit 2025 (Italy)
- Breast Cancer and Cell Biology - Breast Cancer 2025 (Canada)
- Breast Cancer and Cell Biology - Breast Cancer-2025 (Germany)
- Breast Cancer And Immunology - Breast Cancer Summit 2025 (Italy)
- Breast Cancer and Immunology - Breast Cancer 2025 (Canada)
- Breast Cancer and Immunology - Breast Cancer-2025 (Germany)
- Breast Cancer Awareness - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Awareness - Breast Cancer 2025 (Canada)
- Breast Cancer Clinical Trials - Breast Cancer 2025 (Canada)
- Breast Cancer Detection, Prevention and Diagnosis - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Detection, Prevention and Diagnosis - Breast Cancer-2025 (Germany)
- Breast Cancer Detection, Prevention, and Diagnosis - Breast Cancer 2025 (Canada)
- Breast Cancer during pregnancy - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Management - Breast Cancer 2025 (Canada)
- Breast Cancer Management - Breast Cancer-2025 (Germany)
- Breast Cancer Nursing - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Nursing - Breast Cancer 2025 (Canada)
- Breast Cancer Nursing - Breast Cancer-2025 (Germany)
- Breast Cancer Radiation Therapy - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Risk - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Risk - Breast Cancer 2025 (Canada)
- Breast Cancer Risk - Breast Cancer-2025 (Germany)
- Breast Cancer Staging - Breast Cancer 2025 (Canada)
- Breast Cancer Staging - Breast Cancer-2025 (Germany)
- Breast cancer surgery - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Surgery - Breast Cancer 2025 (Canada)
- Breast Cancer Surgery - Breast Cancer-2025 (Germany)
- Breast Cancer Therapies - Breast Cancer Summit 2025 (Italy)
- Breast Cancer Types and Etiology - Breast Cancer 2025 (Canada)
- Breast Cancer- Clinical Trails - Breast Cancer Summit 2025 (Italy)
- Breast Cancer-Clinical Trials - Breast Cancer-2025 (Germany)
- Breast Cancer: Screening, Diagnosis, and Treatment - CANCER2025 (Netherlands)
- Cancer & Stem Cell Therapy - Cancer Meeting Summit 2025 (France)
- Cancer Awareness and Survival - Cancer Meeting Summit 2025 (France)
- Cancer Biology - CANCER BIOLOGY- 2025 (Italy)
- Cancer Biomarkers - Cancer Meeting Summit 2025 (France)
- Cancer Biopsy - Cancer Meeting Summit 2025 (France)
- Cancer Causes and Risk Factors - Cancer Meeting Summit 2025 (France)
- Cancer Cell Biology & Geneti - Cancer Meeting Summit 2025 (France)
- Cancer Control and Survivorship Care - CANCER BIOLOGY- 2025 (Italy)
- Cancer Diagnostics - World Cancer 2025 (UK)
- Cancer Early Detection, Diagnosis and Prognosis - Cancer Meeting Summit 2025 (France)
- Cancer Epidemiology and Biomarkers - Preventive Oncology 2025 (Italy)
- Cancer Epidemiology and Public Health - World Cancer 2025 (UK)
- Cancer Epidemiology and Public Health - CANCER BIOLOGY- 2025 (Italy)
- Cancer Genomics and Epigenetics - CANCER BIOLOGY- 2025 (Italy)
- Cancer Genomics and Precision Oncology - Preventive Oncology 2025 (Italy)
- Cancer Immunology and Immunotherapy - World Cancer 2025 (UK)
- Cancer Immunology and Immunotherapy - Preventive Oncology 2025 (Italy)
- Cancer Immunology and Immunotherapy - CANCER BIOLOGY- 2025 (Italy)
- Cancer Metabolism and Nutritional Interventions - CANCER2025 (Netherlands)
- Cancer Pharmacology and Drug Development - CANCER BIOLOGY- 2025 (Italy)
- Cancer Prevention & Research - Cancer Meeting Summit 2025 (France)
- Cancer Prevention and Early Detection: The Nurse’s Role - World Cancer 2025 (UK)
- Cancer Prevention and Risk Reduction - CANCER2025 (Netherlands)
- Cancer Screening & Chemotherapy - Cancer Meeting Summit 2025 (France)
- Cancer Stem Cells and Therapeutics - CANCER BIOLOGY- 2025 (Italy)
- Cancer Stem Cells and Therapeutics - CANCER BIOLOGY- 2025 (Italy)
- Cancer Stem Cells and Tumor Biology - CANCER2025 (Netherlands)
- Cancer Treatment and Therapeutics - World Cancer 2025 (UK)
- Cancer Vaccines - Cancer Meeting Summit 2025 (France)
- Cancer Vaccines and Personalized Immunization Strategies - Cancer Biology 2025 (UK)
- Cancer Vaccines and Preventive Strategies - CANCER BIOLOGY- 2025 (Italy)
- Cancer Vaccinology and Preventive Vaccines - CANCER2025 (Netherlands)
- CAR-T Cell Therapy and Cell-Based Treatments - CANCER2025 (Netherlands)
- Cardiovascular Biomarker Innovations - Biomarkers Conference 2025 (Italy)
- Case Studies - ORAL CANCER SUMMIT 2025 (France)
- Case Studies - Breast Cancer 2025 (Canada)
- Case Studies - Breast Cancer-2025 (Germany)
- Cellular Mechanisms of Drug Resistance in Cancer - Cancer Biology 2025 (UK)
- Cellular Senescence and Tumor Suppression - Cancer Biology 2025 (UK)
- Cellular Therapies in Cancer Treatment - Cancer Biology 2025 (UK)
- Clinical Trials and Regulatory Aspects in Oncology - CANCER2025 (Netherlands)
- Clinical Trials and Research Innovations - World Cancer 2025 (UK)
- CRISPR and Gene Editing in Cancer Therapy - Cancer Biology 2025 (UK)
- CRISPR/Cas9 in CSC Research - Cancer Stem Cells 2025 (Netherlands)
- CSC and Immunoediting - Cancer Stem Cells 2025 (Netherlands)
- CSC Biomarkers for Early Detection - Cancer Stem Cells 2025 (Netherlands)
- CSC Fate Determination and Differentiation - Cancer Stem Cells 2025 (Netherlands)
- CSC Heterogeneity in Tumors - Cancer Stem Cells 2025 (Netherlands)
- CSC Metabolism and Energy Pathways - Cancer Stem Cells 2025 (Netherlands)
- CSC Niche and Hypoxia - Cancer Stem Cells 2025 (Netherlands)
- CSC Plasticity and Tumor Progression - Cancer Stem Cells 2025 (Netherlands)
- CSC-Derived Exosomes and Communication - Cancer Stem Cells 2025 (Netherlands)
- CSC-Driven Angiogenesis - Cancer Stem Cells 2025 (Netherlands)
- CSC-Driven Resistance to Radiotherapy - Cancer Stem Cells 2025 (Netherlands)
- CSC-Mediated Immunosuppression - Cancer Stem Cells 2025 (Netherlands)
- CSCs and Tumor Microenvironment - Cancer Stem Cells 2025 (Netherlands)
- Diagnostic Imaging in Cancer: Innovations and Future Directions - Preventive Oncology 2025 (Italy)
- Diet and Lifestyle Effect on Breast Cancer - Breast Cancer-2025 (Germany)
- Diet and Lifestyle Effects on Breast Cancer - Breast Cancer 2025 (Canada)
- DNA Damage, Mutation and Cancer - Cancer Meeting Summit 2025 (France)
- Drug Resistance Mechanisms in CSCs - Cancer Stem Cells 2025 (Netherlands)
- Early Detection and Diagnostic - ORAL CANCER SUMMIT 2025 (France)
- Early Detection and Prevention - World Cancer 2025 (UK)
- Early Detection and Screening Innovations - CANCER2025 (Netherlands)
- Emerging Technologies in Cancer Research - World Cancer 2025 (UK)
- Environmental Biomarkers - Biomarkers Conference 2025 (Italy)
- Environmental Carcinogens and Cancer Epidemiology - CANCER2025 (Netherlands)
- Epidemiology - ORAL CANCER SUMMIT 2025 (France)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer Summit 2025 (Italy)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer 2025 (Canada)
- Epidemiology of Breast Cancer and Risk Factors - Breast Cancer-2025 (Germany)
- Epigenetic Biomarkers - Biomarkers Conference 2025 (Italy)
- Epigenetic Modifications and Cancer Treatment - Cancer Biology 2025 (UK)
- Epigenetics and CSC Regulation - Cancer Stem Cells 2025 (Netherlands)
- Ethics in Biomarker Research - Biomarkers Conference 2025 (Italy)
- Exosomes and Cell Communication in Cancer Therapy - Cancer Biology 2025 (UK)
- Future Directions in Oral Cancer Therapy - ORAL CANCER SUMMIT 2025 (France)
- Future Trends in Biomarker Research - Biomarkers Conference 2025 (Italy)
- Genetic and Environmental Factors in Cancer Development - Preventive Oncology 2025 (Italy)
- Genomic Biomarkers - Biomarkers Conference 2025 (Italy)
- Genomics and Cancer Epigenetics - CANCER2025 (Netherlands)
- Geriatric Oral Oncology - ORAL CANCER SUMMIT 2025 (France)
- Gynaecological Cancers - Cancer Meeting Summit 2025 (France)
- Immunotherapy and Cancer Vaccines - CANCER2025 (Netherlands)
- Immunotherapy and CSCs - Cancer Stem Cells 2025 (Netherlands)
- Immunotherapy and Personalized Medicine in Oncology - Cancer Biology 2025 (UK)
- Infectious Disease Biomarkers - Biomarkers Conference 2025 (Italy)
- Inflammation and CSC Activation - Cancer Stem Cells 2025 (Netherlands)
- Inflammatory Breast Cancer - Breast Cancer Summit 2025 (Italy)
- Inflammatory Breast Cancer - Breast Cancer 2025 (Canada)
- Inflammatory Breast Cancer - Breast Cancer-2025 (Germany)
- Inflammatory Disease Biomarkers - Biomarkers Conference 2025 (Italy)
- Innovations in Cancer Diagnostics and Early Detection - Preventive Oncology 2025 (Italy)
- Innovations in Cancer Research - CANCER BIOLOGY- 2025 (Italy)
- Innovative Treatment - ORAL CANCER SUMMIT 2025 (France)
- Liquid Biopsies for Precision Oncology - Cancer Biology 2025 (UK)
- Liquid Biopsies in Oncology - Biomarkers Conference 2025 (Italy)
- Liquid Biopsy and Non-Invasive Diagnostics - CANCER2025 (Netherlands)
- Male Breast Cancer Research - Breast Cancer Summit 2025 (Italy)
- Male Breast Cancer Research - Breast Cancer 2025 (Canada)
- Male Breast Cancer Research - Breast Cancer-2025 (Germany)
- Mammography - Breast Cancer 2025 (Canada)
- Mammography - Breast Cancer-2025 (Germany)
- Medications - ORAL CANCER SUMMIT 2025 (France)
- Metabolic Reprogramming in Cancer Cells - Cancer Biology 2025 (UK)
- Metastatic breast Cancer - Breast Cancer Summit 2025 (Italy)
- Molecular and Genetic Insights in Oral Cancer - ORAL CANCER SUMMIT 2025 (France)
- Molecular Biology of Cancer - World Cancer 2025 (UK)
- Molecular Biology of Cancer - CANCER BIOLOGY- 2025 (Italy)
- Molecular Oncology: From Bench to Bedside - Preventive Oncology 2025 (Italy)
- Molecular Signaling in CSCs - Cancer Stem Cells 2025 (Netherlands)
- Monitoring Chronic Disease with Biomarkers - Biomarkers Conference 2025 (Italy)
- Nanotechnology and CSC Targeting - Cancer Stem Cells 2025 (Netherlands)
- Natural Products and CSC Targeting - Cancer Stem Cells 2025 (Netherlands)
- Neonatal & Pediatric Oncology - Cancer Meeting Summit 2025 (France)
- Neurodegenerative Disease Biomarkers - Biomarkers Conference 2025 (Italy)
- Neurological Cancers & Brain Tumors - Cancer Meeting Summit 2025 (France)
- Novel Screening Methods for Early Detection - Preventive Oncology 2025 (Italy)
- Nursing Leadership and Professional Development in Oncology - World Cancer 2025 (UK)
- Nutrition, Lifestyle, and Cancer Prevention - Preventive Oncology 2025 (Italy)
- Oncologic Imaging and Diagnostics - CANCER BIOLOGY- 2025 (Italy)
- Oncology Nursing and Patient Care - CANCER2025 (Netherlands)
- Oncology Nursing Care - Cancer Meeting Summit 2025 (France)
- Oncology Radiology, Nanotechnology - Cancer Meeting Summit 2025 (France)
- Oncolytic Virus and Cancer - Cancer Meeting Summit 2025 (France)
- Oral Cavity Melanoma - ORAL CANCER SUMMIT 2025 (France)
- Organ Specific Cancer - Cancer Meeting Summit 2025 (France)
- Palliative Care and Quality of Life - CANCER2025 (Netherlands)
- Pediatric Biomarkers - Biomarkers Conference 2025 (Italy)
- Pediatric Oncology - World Cancer 2025 (UK)
- Pediatric Oncology - CANCER BIOLOGY- 2025 (Italy)
- Pediatric Oncology Innovations - CANCER2025 (Netherlands)
- Pediatric oral cancer - ORAL CANCER SUMMIT 2025 (France)
- Personalized Cancer Medicine and Targeted Therapy - Preventive Oncology 2025 (Italy)
- PET Scans in High-Risk Populations for Cancer Prevention - Preventive Oncology 2025 (Italy)
- Pharmacovigilance and Drug Safety in Oncology - CANCER2025 (Netherlands)
- Precision Medicine and Biomarkers - Biomarkers Conference 2025 (Italy)
- Precision Oncology and Personalized Medicine - CANCER2025 (Netherlands)
- Precision Oncology: Targeting Cancer at the Molecular Level - Cancer Biology 2025 (UK)
- Prevention Strategies - ORAL CANCER SUMMIT 2025 (France)
- Preventive Oncology in Low- and Middle-Income Countries - Preventive Oncology 2025 (Italy)
- Proteomics in Biomarker Discovery - Biomarkers Conference 2025 (Italy)
- Psychiatric Biomarkers - Biomarkers Conference 2025 (Italy)
- Psychosocial Oncology and Mental Health - CANCER2025 (Netherlands)
- Public Health Strategies in Reducing Cancer Burden - Preventive Oncology 2025 (Italy)
- Radiation Oncology and Radiotherapy Advances - CANCER2025 (Netherlands)
- Radiation Therapy - CANCER BIOLOGY- 2025 (Italy)
- Radiation Treatment - ORAL CANCER SUMMIT 2025 (France)
- Radiology - Breast Cancer 2025 (Canada)
- Radiology - Breast Cancer-2025 (Germany)
- Rare Cancers and Orphan Drugs - CANCER2025 (Netherlands)
- Rehabilitation - ORAL CANCER SUMMIT 2025 (France)
- RNA-based Therapies in Cancer - Cancer Biology 2025 (UK)
- Role of AI and Machine Learning in Cancer Diagnosis - Preventive Oncology 2025 (Italy)
- Role of Artificial Intelligence in Precision Cancer Treatment - Cancer Biology 2025 (UK)
- Role of CSCs in Metastasis - Cancer Stem Cells 2025 (Netherlands)
- Role of EMT in CSC Plasticity - Cancer Stem Cells 2025 (Netherlands)
- Role of Nutrition in Oral Cancer Management - ORAL CANCER SUMMIT 2025 (France)
- Role of Organoids and 3D Cultures in Personalized Cancer Treatment - Cancer Biology 2025 (UK)
- Role of Stem Cells in Cancer Progression and Treatment - Cancer Biology 2025 (UK)
- Squamous cell carcinoma - ORAL CANCER SUMMIT 2025 (France)
- Supportive Care and Palliative Medicine - World Cancer 2025 (UK)
- Surgical and Clinical Oncology - Cancer Meeting Summit 2025 (France)
- Surgical Oncology and Minimally Invasive Techniques - CANCER2025 (Netherlands)
- Targeted Therapy and Molecular Diagnostics - CANCER2025 (Netherlands)
- Targeting Cancer Cell Cycle for Therapeutic Advances - Cancer Biology 2025 (UK)
- Targeting CSC Dormancy - Cancer Stem Cells 2025 (Netherlands)
- Targeting CSC-Specific Surface Markers - Cancer Stem Cells 2025 (Netherlands)
- Telemedicine and Digital Health in Oncology - CANCER2025 (Netherlands)
- Therapy Resistance and CSCs - Cancer Stem Cells 2025 (Netherlands)
- Translational Biomarker Research - Biomarkers Conference 2025 (Italy)
- Tumor Heterogeneity and Personalized Treatment Approaches - Cancer Biology 2025 (UK)
- Tumor Microenvironment - CANCER BIOLOGY- 2025 (Italy)
- Tumor Microenvironment and Its Role in Cancer Progression - Preventive Oncology 2025 (Italy)
- Tumor Microenvironment and Metastasis - CANCER2025 (Netherlands)
- Tumour Virology, Immunology & Cellular Pathology - Cancer Meeting Summit 2025 (France)
- Verrucous carcinoma - ORAL CANCER SUMMIT 2025 (France)